Advanced search
Add to list

Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial

(2003) CANCER. 97(1). p.40-45
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
BIGANZOLI, L, T CUFER, P BRUNING, et al. “Doxorubicin-paclitaxel - A Safe Regimen in Terms of Cardiac Toxicity in Metastatic Breast Carcinoma Patients. Results from a European Organization for Research and Treatment of Cancer Multicenter Trial.” CANCER 97.1 (2003): 40–45. Print.
APA
BIGANZOLI, L., CUFER, T., BRUNING, P., COLEMAN, R., Duchateau, L., RAPOPORT, B., NOOIJ, M., et al. (2003). Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial. CANCER, 97(1), 40–45.
Chicago author-date
BIGANZOLI, L, T CUFER, P BRUNING, RE COLEMAN, Luc Duchateau, B RAPOPORT, M NOOIJ, et al. 2003. “Doxorubicin-paclitaxel - A Safe Regimen in Terms of Cardiac Toxicity in Metastatic Breast Carcinoma Patients. Results from a European Organization for Research and Treatment of Cancer Multicenter Trial.” Cancer 97 (1): 40–45.
Chicago author-date (all authors)
BIGANZOLI, L, T CUFER, P BRUNING, RE COLEMAN, Luc Duchateau, B RAPOPORT, M NOOIJ, F DELHAYE, D MILES, A SULKES, A HAMILTON, and M PICCART. 2003. “Doxorubicin-paclitaxel - A Safe Regimen in Terms of Cardiac Toxicity in Metastatic Breast Carcinoma Patients. Results from a European Organization for Research and Treatment of Cancer Multicenter Trial.” Cancer 97 (1): 40–45.
Vancouver
1.
BIGANZOLI L, CUFER T, BRUNING P, COLEMAN R, Duchateau L, RAPOPORT B, et al. Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial. CANCER. 2003;97(1):40–5.
IEEE
[1]
L. BIGANZOLI et al., “Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial,” CANCER, vol. 97, no. 1, pp. 40–45, 2003.
@article{210424,
  author       = {BIGANZOLI, L and CUFER, T and BRUNING, P and COLEMAN, RE and Duchateau, Luc and RAPOPORT, B and NOOIJ, M and DELHAYE, F and MILES, D and SULKES, A and HAMILTON, A and PICCART, M},
  issn         = {0008-543X},
  journal      = {CANCER},
  language     = {eng},
  number       = {1},
  pages        = {40--45},
  title        = {Doxorubicin-paclitaxel - A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial},
  volume       = {97},
  year         = {2003},
}

Web of Science
Times cited: